Clorox's two recent acquisitions of Aplicare and HealthLink will put slight dent in 2012 profit but won't impact plans for dividends, share repurchases, company says
Michelle Rivera
LOS ANGELES
,
January 5, 2012
(Industry Intelligence)
–
Clorox Co.'s two recent acquisitions of Connecticut-based Aplicare Inc. and Florida-based HealthLink, providers of infection control products for the healthcare industry, will put a slight dent in the company's profit for 2012 but won't have any impact on its dividends or share repurchases plans, Reuters reported Jan. 5.
The company spent about US$80 million to US$90 million combined for the two companies.
According to Don Knauss, Clorox's chairman and CEO, the acquisitions are supported by the rapid growth of the use of infection control products as providers push to combat healthcare-associated infections.
Clorox said Aplicare's and HealthLink's combined sales could represent more than 1% of the company's annual sales going forward, Reuters reported.
The primary source of this article is Reuters, London, England, on Jan. 5, 2011.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
